Researchers at MD Anderson Cancer Center have used spatial transcriptomics to chart the internal architecture of ...
SurvivorNet on MSN
New approval means more bladder cancer patients can access powerful immunotherapy combination: What to know about Keytruda + Padcev
A new treatment combination - Keytruda plus Padcev - is now approved for use before and after bladder‑removal surgery, ...
The increasingly more popular combination of Padcev and Keytruda has expanded its bladder cancer territory once again. | The ...
TAR-200, a gemcitabine-releasing system, received FDA priority review for high-risk non-muscle invasive bladder cancer unresponsive to BCG. Phase 2b SunRISe-1 trial data showed an 82.4% complete ...
USA: A new systematic review published in the Cochrane Database of Systematic Reviews suggests that blue light-enhanced ...
Medically Integrated Dispensing Pharmacy: ASCO-NCODA (Network for Collaborative Oncology Development & Advancement) Standards Update This systematic review included all randomized, quasi‐randomized, ...
Urothelial cancer (UC) is the most common histology seen in bladder tumors. The 2022 WHO classification of urinary tract tumors includes a list of less common subtypes (formerly known as variants) for ...
Surgery for advanced bladder cancer includes transurethral resection of the bladder tumor (TURBT) to remove tumors and cystectomy to remove all or part of the bladder, with the choice depending on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results